换一批Sequential high-dose cytarabine and mitoxantrone (S-HAM) versus standard double induction in acute myeloid leukemia-a phase 3 study.
第一作者：
Jan,Braess
第一单位：
Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany. Jan.Braess@barmherzige-regensburg.de.;Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany. Jan.Braess@barmherzige-regensburg.de.
作者：
Jan,Braess [1]
;
Susanne,Amler [2]
;
Karl-Anton,Kreuzer [3]
;
Karsten,Spiekermann [4]
;
Hans Walter,Lindemann [5]
;
Eva,Lengfelder [6]
;
Ullrich,Graeven [7]
;
Peter,Staib [8]
;
Wolf-Dieter,Ludwig [9]
;
Harald,Biersack [10]
;
Yon-Dschun,Ko [11]
;
Michael J,Uppenkamp [12]
;
Maike,De Wit [13]
;
Stefan,Korsten [14]
;
Rudolf,Peceny [15]
;
Tobias,Gaska [16]
;
Xaver,Schiel [17]
;
Dirk M,Behringer [18]
;
Michael G,Kiehl [19]
;
Bettina,Zinngrebe [20]
;
Gerald,Meckenstock [21]
;
Eva,Roemer [22]
;
Dirk,Medgenberg [23]
;
Ernst,Spaeth-Schwalbe [24]
;
Gero,Massenkeil [25]
;
Heidrun,Hindahl [26]
;
Rainer,Schwerdtfeger [27]
;
Guido,Trenn [28]
;
Cristina,Sauerland [29]
;
Raphael,Koch [29]
;
Martin,Lablans [30]
;
Andreas,Faldum [29]
;
Dennis,Görlich [29]
;
Stefan K,Bohlander [31]
;
Stephanie,Schneider [4]
;
Annika,Dufour [4]
;
Christian,Buske [32]
;
Michael,Fiegl [4]
;
Marion,Subklewe [4]
;
Birgit,Braess [33]
;
Michael,Unterhalt [4]
;
Anja,Baumgartner [4]
;
Bernhard,Wörmann [34]
;
Dietrich,Beelen [35]
;
Wolfgang,Hiddemann [4]
;
AML-CG
作者单位：
Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany. Jan.Braess@barmherzige-regensburg.de.;Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany. Jan.Braess@barmherzige-regensburg.de.
[1]
Insitute for Biostatistics and Clinical Research, University Hospital, Münster, Germany.;Friedrich Löffler Institute, Federal Research Centre, Greifswald-Insel Riems, Germany.
[2]
Department of Internal Medicine I, University Hospital, Cologne, Germany.
[3]
Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany.
[4]
Department of Hematology and Oncology, Catholic Hospital, Hagen, Germany.
[5]
Department of Medicine III, University Hospital, Mannheim, Germany.
[6]
Department of Medicine I, Hospital Maria Hilf, Mönchengladbach, Germany.
[7]
Department of Hematology and Medical Oncology, St. Antonius Hospital, Eschweiler, Germany.
[8]
Department of Hematology and Oncology and Tumor Immunology, Helios Hospital, Berlin-Buch, Germany.
[9]
Department of Medicine I, University Hospital, Lübeck, Germany.
[10]
Department of Medicine I, Johanniter Hospital, Bonn, Germany.
[11]
Department of Medicine A, Klinikum Ludwigshafen, Ludwigshafen, Germany.
[12]
Department of Hematology, Oncology and Palliative Care, Vivantes Klinikum Neukölln, Berlin, Germany.
[13]
Department of Medicine, Vinzenz Pallotti Hospital, Bergisch-Gladbach, Germany.
[14]
Department of Hematology and Oncology, Klinikum Osnabrück, Osnabrück, Germany.
[15]
Department of Hematology and Oncology, St. Josef Hospital, Paderborn, Germany.
[16]
Department of Hematology and Oncology, Klinikum Harlaching, Munich, Germany.
[17]
Department of Hematology, Oncology and Palliative Care, Augusta Hospital, Bochum, Germany.
[18]
Department of Medicine I, Klinikum Frankfurt/Oder, Frankfurt/Oder, Germany.
[19]
Department of Hematology, Oncology and Palliative Care, Evangelisches Krankenhaus, Bielefeld, Germany.
[20]
Department of Medical Oncology, Radiooncology, Hematology and Palliative Care, St. Josef Hospital, Gelsenkirchen, Germany.
[21]
Department of Hematology and Oncology, Klinikum Idar-Oberstein, Idar-Oberstein, Germany.
[22]
Department of Medicine III, Klinikum Leverkusen, Leverkusen, Germany.
[23]
Department of Medicine, Vivantes Klinikum Spandau, Berlin, Germany.
[24]
Department of Medicine II, Klinikum Gütersloh, Gütersloh, Germany.
[25]
Department of Medicine I, St. Johannes Hospital, Dortmund, Germany.
[26]
Department for Bone Marrow and Blood Stem Cell Transplantation, DKD Deutsche Klinik für Diagnostik, Wiesbaden, Germany.
[27]
Department of Medicine I, Knappschaftskrankenhaus, Bottrop, Germany.
[28]
Insitute for Biostatistics and Clinical Research, University Hospital, Münster, Germany.
[29]
Insitute for Biostatistics and Clinical Research, University Hospital, Münster, Germany.;Division of Medical Informatics in Translational Oncology, DKFZ German Cancer Research Center, Heidelberg, Germany.
[30]
Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany.;Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
[31]
Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany.;Institute of Experimental Cancer Research, University Hospital, Ulm, Germany.
[32]
Department of Oncology and Hematology, Hospital Barmherzige Brüder, Regensburg, Germany.;Department of Medicine III, University Hospital LMU Campus Grosshadern, Munich, Germany.
[33]
German Society of Hematology and Oncology DGHO, Berlin, Germany.
[34]
Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
[35]
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);阿糖胞苷(Cytarabine);女(雌)性(Female);人类(Humans);白血病, 髓样, 急性(Leukemia, Myeloid, Acute);男(雄)性(Male);中年人(Middle Aged);米托蒽醌(Mitoxantrone);缓解诱导(Remission Induction);青年人(Young Adult)
DOI
10.1038/s41375-018-0268-9
PMID
30275528
发布时间
2020-03-09
- 浏览9
Leukemia
Leukemia
2558-2571页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
